BTK inhibitors in mantle cell lymphoma, explained | CION Cancer Clinics

A BTK inhibitor is a tablet or capsule that blocks a signal mantle cell lymphoma cells need to survive and grow. It is taken by mouth every day at home, usually for as long as it keeps working and you can manage it.

How it works, in plain words

Mantle cell lymphoma grows from B cells, a kind of white blood cell. These cells carry a switch on their surface that keeps telling them to stay alive. BTK, short for Bruton's tyrosine kinase, is a protein that passes that message along inside the cell. Block BTK and the message stops. The lymphoma cells struggle to survive, and lymph nodes often shrink.

Where it fits in treatment

For many years these medicines were used mainly when the lymphoma came back after chemotherapy. They are now also being used earlier, added to first treatment in some people, especially older people and those whose lymphoma carries a TP53 change that makes chemotherapy work less well. Whether it is right for you at the start depends on your biopsy, your health and what is available and approved.

Alone or with other treatment?

A BTK inhibitor can be given on its own, or combined with rituximab, an antibody drip, or with chemotherapy or another tablet called venetoclax. The combination chosen depends on whether this is your first treatment or a later one, and on how fit you are. Combinations can work more strongly but usually bring more side effects, so the team weighs both before suggesting one.

These medicines are not right for everyone. People with certain heart rhythm problems, poorly controlled blood pressure or a high bleeding risk may need a different plan. People who must take a strong blood thinner need a careful discussion, because the two together raise the chance of bleeding. Someone who lives far from any hospital and cannot easily come for regular checks may also need a plan built around that, because the early months need close watching.

Other medicines matter

Some antifungal and antibiotic medicines, some heart medicines and even grapefruit can change how much of the BTK inhibitor stays in your blood. Tell every doctor and pharmacist you see that you take it. Before any surgery or dental work, tell your haematologist early so they can decide whether to pause it.

What this page cannot tell you

It cannot tell you whether a BTK inhibitor will work for your lymphoma, how long it may keep it under control, or which medicine your team will choose. Those answers depend on your biopsy, earlier treatment and health. Ask your haematologist directly about your own outlook.